Twitter | Pretraživanje | |
Pretraživanje Osvježi
Lora Bogoeva 21. lis
A glimpse into the clinical trials of the future. Join the Discussion
Reply Retweet Označi sa "sviđa mi se"
Lora Bogoeva 22. lis
Striving for excellence in clinical monitoring
Reply Retweet Označi sa "sviđa mi se"
Lora Bogoeva 21. lis
Reply Retweet Označi sa "sviđa mi se"
Life Sciences Network marcus evans 12 h
Jenny Wakefield, Director, Senior Clinical Trial Head at Incyte, will be part of our panel discussion on what it takes to accelerate study start-up. Head to the Evolution Summit page for details:
Reply Retweet Označi sa "sviđa mi se"
PharmaOut 19. ruj
Thank you for hosting another wonderful Evolution Summit last week in San Diego! We had a great time connecting with Industry leaders and look forward to meeting again in Boston!
Reply Retweet Označi sa "sviđa mi se"
CTTI 22. velj
Join CTTI Executive Director Monday at , where she will discuss bridging the gap between the pharma industry and digitization
Reply Retweet Označi sa "sviđa mi se"
Rho 24. velj
Marcelo Bigal discusses his lessons learned from developing drugs for chronic migraine and Huntington’s disease—don’t exclude the patients most in need from your clinical trials and consider the burden to patients of your trial design
Reply Retweet Označi sa "sviđa mi se"
Dany DeGrave 19. stu
Odgovor korisniku/ci @meEventsPharma @marcusevans
Thanks for the opportunity to share these learnings.
Reply Retweet Označi sa "sviđa mi se"
Life Sciences Network marcus evans 4. velj
Emily Roberts-Thomson, VP, Clinical Operations at Acerta Pharma will be giving her insights on 'Settling with the Right CRO and Augmenting the Relationship' at the Evolution Summit --->
Reply Retweet Označi sa "sviđa mi se"
Life Sciences Network marcus evans 3. velj
Joining us as a presenter at the Evolution Summit this March is Dmitri Lissin, Chief Medical Officer at Pharmaceuticals. Trials Find out more:
Reply Retweet Označi sa "sviđa mi se"
Life Sciences Network marcus evans 31. sij
Craig Ostroff, Vice President & Head, Cardiovascular & Metabolic Disease, Retinal Gene Therapy Areas, Global Regulatory Affairs at Janssen, will be presenting at the Evolution Summit this March – Be with the leaders!
Reply Retweet Označi sa "sviđa mi se"
Life Sciences Network marcus evans 30. sij
Excited to welcome Chad Swanson, Executive Director, Neurology Business Group at Eisai, Inc., as a speaker at the Evolution Summit this March 2-4 in Napa, CA. Further details here:
Reply Retweet Označi sa "sviđa mi se"
Life Sciences Network marcus evans 29. sij
Pavel Farkas, Senior Director, Global Generics Clinical R&D at TEVA will be joining us for an interactive round table discussion on 'Advancing Global Development of Generic Drugs' at the Evolution Summit this March. More details here:
Reply Retweet Označi sa "sviđa mi se"
Life Sciences Network marcus evans 28. sij
A warm welcome to Anh Nguyen, Director, Strategy Operations at Xeris Pharmaceuticals Inc., who will be joining us as a speaker at the upcoming Evolution Summit this March. More details here:
Reply Retweet Označi sa "sviđa mi se"
Life Sciences Network marcus evans 27. sij
The Evolution Summit is delighted to welcome Michelle Shogren, Senior Director of Innovation - Pharma R&D Clinical Operations at Bayer Pharmaceuticals, as a speaker! View details on the program here:
Reply Retweet Označi sa "sviđa mi se"
Biotechgate 23. sij
How to surpass recruitment, retention and patient engagement goals? See what industry leaders have to say at the 21st in March 2020. Find out more:
Reply Retweet Označi sa "sviđa mi se"
Biotechgate 22. sij
are proud to be a media partner for the Evolution Summit taking place in March, register your place here
Reply Retweet Označi sa "sviđa mi se"
Life Sciences Network marcus evans 16. pro
Check out the November issue of - one of our Official Media Partners for the upcoming Evolution Summit next March in California. Learn more here:
Reply Retweet Označi sa "sviđa mi se"
Veristat, LLC 19. stu
Shaheen Limbada presenting live at the Evolution Summit Boston today on “How to Manage E6(R2) Compliance as it Relates to Risk? A Guide to Selecting and Presenting Key Risk Indicators (KRIs) to Ensure R2 Compliance”.
Reply Retweet Označi sa "sviđa mi se"
Dany DeGrave 18. stu
Clinical science is no longer about the “average person” ~ Dr. Ulo Palm at Evolution by
Reply Retweet Označi sa "sviđa mi se"